A. Novack

Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer

M. Spannagl, P. Turecek, H. Ott, 2019, Platelets.

Design, synthesis and SAR of a novel series of heterocyclic phenylpropanoic acids as GPR120 agonists.

Z. Sui, Xuqing Zhang, W. Murray, 2017, Bioorganic & medicinal chemistry letters.

Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxis

J. Epstein, G. Kenet, D. Nugent, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Global Post-Authorization Safety Surveillance Study: real-world data on prophylaxis and on-demand treatment using FEIBA (an activated prothrombin complex concentrate)

C. Négrier, F. Baghaei, A. Gringeri, 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand

J. Hay, J. Epstein, E. Neufeld, 2016, Journal of managed care & specialty pharmacy.

Efficacy and safety of OBI‐1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A

E. Gomperts, A. Shapiro, R. Kruse-Jarres, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Formation of 3,4-dimethyl-2-pyrones from allene carboxylates and 2-silyloxydienes via 3-carboethoxyethylidene cyclobutanols

M. Jung, A. Novack, 2005 .

Versatile diastereoselectivity in formal [3,3]-sigmatropic shifts of substituted 1-alkenyl-3-alkylidenecyclobutanols and their silyl ethers.

M. Jung, N. Nishimura, A. Novack, 2005, Journal of the American Chemical Society.